VENTX and NANOG are highly expressed in CD34+ leukemic stem cells (LSC, a subpopulation responsible for drug resistance, metastasis, and leukemia relapse) and their depletion blocks AML proliferation and growth [161,162,163]. Here, NANOG is linked to leukemia.